Impact of sacubitril–valsartan combination in patients with chronic heart failure and sleep apnoea syndrome: the ENTRESTO‐SAS study design

AIMS: Sleep‐disordered breathing (SDB) is a highly prevalent co‐morbidity in patients with chronic heart failure (CHF) and can play a detrimental role in the pathophysiology course of CHF. However, the best way to manage SDB in CHF remains a matter of debate. Sacubitril–valsartan has been included i...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:ESC Heart Fail
Autors principals: Jaffuel, Dany, Molinari, Nicolas, Berdague, Philippe, Pathak, Atul, Galinier, Michel, Dupuis, Marion, Ricci, Jean‐Etienne, Mallet, Jean‐Pierre, Bourdin, Arnaud, Roubille, François
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2018
Matèries:
Study Design
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5933955/
https://ncbi.nlm.nih.gov/pubmed/29469206
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12270
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars